Symptom clusters in patients with newly-diagnosed brain tumors

Journal of Supportive Oncology

Volumn 5, Issue 9, 2007, Pages

  Gleason Jr , John F ^a   Case, Douglas ^a   Rapp, Stephen R ^a   Ip, Edward ^a   Naughton, Michelle ^a   Butler Jr , Jerome M ^a   McMullen, Kevin ^a   Stieber, Volker ^a   Saconn, Paul ^a   Shaw, Edward G ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMETHYLPHENIDATE; PLACEBO;

ADULT; AGED; ANXIETY; ARTICLE; BRAIN RADIATION; BRAIN TUMOR; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL TRIAL; CLUSTER ANALYSIS; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DYSLEXIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MULTIDIMENSIONAL SCALING; MULTIPLE CYCLE TREATMENT; PHASE 3 CLINICAL TRIAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; UNSPECIFIED SIDE EFFECT;

ADULT; AFFECT; AGED; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM STIMULANTS; CLUSTER ANALYSIS; DOUBLE-BLIND METHOD; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LANGUAGE; MALE; METHYLPHENIDATE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; STEREOISOMERISM;

EID: 35648999960     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30. [15661684]
2. Greenberg HS, Chandler WF, Sandler HM. Brain Tumors. Oxford, England: Oxford University Press; 1999:299-317.
3. Posner JB. Brain metastases-1995: a brief review. J Neurooncol 1996;27:287-293.[8847563]
4. Nussbaum ES, Djalilian HR, Cho KH, Hall WA. Brain metastases: histology, multiplicity, surgery, and survival. Cancer 1996;78:1781-1788. [8859192]
5. Shaw EG. Central nervous system overview. In: Gunderson LL, Tepper JE, eds. Clinical Radiation Oncology. Philadelphia, Pa: Churchill-Livingstone; 2000.
6. Shaw EG, Gaspar LE, Gibbs FA, et al. Multiple brain metastases. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000;215(suppl): 1121-1128. [11037536]
7. Markesbery WR, Brooks WH, Gupta GD, Young AB. Treatment for patients with cerebral metastases. Arch Neurol 1978;35:754-756.[718475]
8. Archibald YM, Lunn D, Ruttan LA, et al. Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 1994,80:247-253. [8283263]
9. Scheibel RS, Meyers CA, Levin VA. Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location,and treatment. J Neurooncol 1996;30:61-69. [8865004]
10. Taphoorn MJ, Schiphorst AK, Snoek FJ, et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 1994,36:48-54. [8024261]
11. Wefel JS, Kayl AE, Meyers CA. Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. Br J Cancer 2004,90:1691-1696. [15150608]
12. Dodd M, Janson S, Facione N, et al. Advancing the science of symptom management. J Adv Nurs 2001;33:668-676. [11298204]
13. Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 2001;28.465-470. [11338755]
14. Kim HJ, McGuire DB, Tulman L, Barsevick AM. Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 2005;28:270-282.[16046888]
15. Dodd MJ, Miaskowski C, Lee KA. Occurrence of symptom clusters. J Natl Cancer Inst Monogr 2004,32:76-78. [15263044]
16. Miaskowski C, Dodd M, Lee K. Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr 2004;32:17-21.[15263036]
17. Butler J Jr, Case D, Lesser G, et al. A phase III, double blind, prospective randomized clinical trial of effect of d-threo-methylphenidate HCI (d-MPH) on quality of life in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Physics. In press.
18. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of general measure. J Clin Oncol 1993;11:570-579. [8445433]
19. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA. The Functional Assessment of Cancer Therapy (FACT) scale: development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 1995;75:1151-1161. [7850714]
20. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
21. Beeber LS, Shea J, McCorkle R. The center for epidemiologic studies depression scale as a measure of depressive symptoms in newly diagnosed patients. J Psychosoc Oncol 1998;16:1-20.
22. Katz MR, Kopek N, Waldron J, Devins GM, Tomlinson G. Screening for depression in head and neck cancer. Psychooncology 2004; 13:269-280. [1505473]
23. Johnson RA, Wichern DW. Applied Multivariate Statistical Analysis. Englewood Cliffs, NJ: Prentice Hall; 1982.
24. Watson R. Publishing the results of factor analysis: interpretation and presentation. J Adv Nurs 1998;28:1361-1363. [9888383]
25. Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol 2004;3:159-168. [14980531]
26. Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 2006;24:1305-1309. [16525186]
27. Weitzner MA. Psychosocial and neuropsychiatric aspects of patients with primary brain tumors. Cancer Invest 1999;17:285-291. [10225009]
28. Taphoorn MJ, Heimans JJ, Snoek FJ, et al. Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry 1992;55:372-376. [1602310